Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Yasuko Namikawa"'
Publikováno v:
Frontiers in Medical Technology, Vol 6 (2024)
IntroductionThe wearable cyborg Hybrid Assistive Limb (HAL) is a therapeutic exoskeletal device that provides voluntary gait assistance using kinematic/kinetic gait data and bioelectrical signals. By utilizing the gait data automatically measured by
Externí odkaz:
https://doaj.org/article/7470d01af9fe4063bbb91c7338769c27
Publikováno v:
SIGGRAPH Asia 2022 XR.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::adbd8b1d5f466724d93e44c8e290e3bc
https://doi.org/10.1145/3550472.3558416
https://doi.org/10.1145/3550472.3558416
Publikováno v:
2022 IEEE International Symposium on Mixed and Augmented Reality (ISMAR).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5af5e51b2e1c88419425592db953e0d4
https://doi.org/10.1109/ismar55827.2022.00031
https://doi.org/10.1109/ismar55827.2022.00031
Publikováno v:
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference. 2021
Cybernic treatment with a wearable cyborg Hybrid Assistive Limb for medical use (Medical HAL) improves ambulatory function in patients with progressive neuromuscular diseases. The progress of cybernic treatment is evaluated based on the change in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf7668419a9bd9542ab2c299dc1dc9d4
https://pubmed.ncbi.nlm.nih.gov/34892652
https://pubmed.ncbi.nlm.nih.gov/34892652
Autor:
Akito Tanaka, Yoshihiko Sakata, Jiro Seki, Yukio Motoyama, Hisashi Takasugi, Yasuko Namikawa, Keizo Yoshida, Jiro Fujisaki, Miwako Dohi
Publikováno v:
European Journal of Pharmacology. 243:179-184
The anti-platelet actions of 1-[(4,5-bis(4-methoxyphenyl)-2- thiazoyl)carbonyl]-4-methylpiperazine hydrochloride (FR122047) were investigated in vitro and in vivo. FR122047 was 100 times more potent than aspirin against arachidonic acid- and collagen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f7dac2dfeaf495253d59433da137e48
https://doi.org/10.1016/0014-2999(93)90378-u
https://doi.org/10.1016/0014-2999(93)90378-u
Autor:
Takaharu Ono, Miho Sato, Yoshihiko Sakata, Haruo Horiai, Jiro Seki, Yasuko Namikawa, Yukio Motoyama
Publikováno v:
Thrombosis Research. 65:55-63
TFC-612 inhibited thrombus formation on wire coils inserted into the lumen of the inferior vena cava of rats after 5 oral doses of 1.0 and 3.2 mg/kg and subcutaneous doses of 1.0 and 3.2 pg/rat/hr. This compound showed slight inhibition of platelet a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e9677847c9c39e8e68eca285e478315
https://doi.org/10.1016/0049-3848(92)90225-y
https://doi.org/10.1016/0049-3848(92)90225-y
Autor:
Jiro Seki, Yukio Motoyama, Takashi Asada, Yoshihiko Sakata, Haruo Horiai, Yasuko Namikawa, Takaharu Ono
Publikováno v:
Thrombosis Research. 63:29-38
The anti-platelet activities of TFC-612, methyl 6-(((1R, 2S, 3R)-3-hydroxy-2-((1E, 3S, 5R)-3-hydroxy-5-methyl-1-nonenyl)-5- oxocyclopentyl) thio)hexanoate, were compared to prostaglandin E1 (PGE1). TFC-612 inhibited human, guinea-pig and rabbit plate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c37fc4fd8654915682ac4b5fdf4807b5
https://doi.org/10.1016/0049-3848(91)90267-z
https://doi.org/10.1016/0049-3848(91)90267-z